Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2024 (11)
  • 2023 (21)
  • 2022 (21)
  • 2021 (52)
  • 2020 (11)
  • 2019 (1)

Subject

  • Prescription Drugs (57)
  • Pharmaceuticals/Pharmacists/Physicians (45)
  • Drug Trafficking (43)
  • Diversion Division (42)
  • Synthetic drugs (36)
  • Seizures (Drugs/Property) (30)
  • Task Forces/Task Force Officers (26)
  • Major Law Enforcement Operation (17)
  • Outreach/Drug Prevention (17)
  • Overdose (16)
  • OCDETF/Task Force (13)
  • Arrests/Convictions - Major (12)
  • Fake Pills (12)
  • Guilty Plea (8)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Guns/Weapons (6)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (2491)
  • Methamphetamine (2060)
  • Cocaine (1860)
  • Heroin (1164)
  • Marijuana (Cannabis) (335)
  • Oxycodone (276)
  • Synthetic Opioids (146)
  • Ecstasy/MDMA (49)
  • Hydromorphone (37)
  • Benzodiazepines (23)
  • Morphine (20)
  • Amphetamines (18)
  • Steroids (18)
  • Ketamine (14)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • LSD (10)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (4)
  • GHB (2)
  • Barbiturates (1)
  • Opioids (119)
  • Peyote & Mescaline (1)

Field Division

  • Washington, DC (55)
  • Miami (9)
  • Atlanta (8)
  • Seattle (8)
  • San Francisco (6)
  • Dallas (5)
  • Headquarters (5)
  • New England (5)
  • Chicago (4)
  • Houston (4)
  • New York (3)
  • St. Louis (3)
  • New Jersey (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
Clear All Results
PRESS RELEASE

Ferry County Hospital District Agrees to Pay $15,000 Penalty and Implement Corrective Actions to Address Improper Opioid Dispensing Practices at Republic Pharmacy

October 02, 2023
SPOKANE, Wash.– The Ferry County Hospital District agreed to pay a $15,000 Controlled Substances Act penalty and to institute corrective actions in regards to opioid prescribing practices at Republic Drug Store, a pharmacy in Republic, Washington, that Ferry County Hospital District purchased in January 2021 and has continued to operate...
October 02, 2023
PRESS RELEASE

New Hampshire Doctor Indicted for Unlawfully Distributing Opioids and Benzodiazepines

September 19, 2023
CONCORD, N.H. – A doctor practicing in the north country of New Hampshire was indicted in connection with his unlawful distribution of opioids and benzodiazepines, U.S. Attorney Jane E. Young announces. Robert G. Soucy Jr., D.O., 70, of Columbia, New Hampshire, was indicted on 12 counts of distribution of controlled...
September 19, 2023
PRESS RELEASE

19 Arrested on Federal Charges Trafficking Meth, Fentanyl, Heroin, and Cocaine in Charlottesville, VA

September 07, 2023
CHARLOTTESVILLE, Va. – A federal grand jury in Charlottesville, Virginia has indicted 17 individuals as part of a large-scale drug conspiracy that distributed more than 500 grams of methamphetamine, fentanyl, heroin, and cocaine in and around the Charlottesville region. The 37-count indictment, returned under seal August 29, 2023, partially unsealed...
September 07, 2023
PRESS RELEASE

DEA Washington Division Encourages Back to School Drug Awareness and Education

September 05, 2023
WASHINGTON, D.C. – As students return to school across the DMV, the DEA's Washington Division urges families to have open conversations about the dangers of drug experimentation and use. “Our citizens, especially our youth, are being exposed to an illicit drug supply that is more dangerous than ever before, making...
September 05, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

July 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
July 06, 2023
PRESS RELEASE

Indictment Charges Alleged Members of Drug Trafficking Organization in Drug, Gun and Money Laundering Charges

June 27, 2023
WASHINGTON – This morning, law enforcement agents from the Metropolitan Police Department (MPD), Drug Enforcement Administration (DEA), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), Federal Bureau of Investigation (FBI), and the Internal Revenue Service Criminal Investigation (IRS-CI) arrested 12 alleged members of a violent drug trafficking organization (“DTO”), known...
June 27, 2023
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

June 26, 2023
NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
June 26, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

June 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
June 23, 2023
PRESS RELEASE

San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids

June 22, 2023
SAN JOSE, Calif. – A federal jury yesterday convicted family medicine physician Donald Siao of twelve counts of distributing the controlled substances Oxycodone and Hydrocodone outside the scope of his usual professional practice and without a legitimate medical purpose, announced United States Attorney Ismail J. Ramsey, Drug Enforcement Administration (DEA)...
June 22, 2023
PRESS RELEASE

Denton Physician Sentenced for Over-Prescribing Opioids

May 19, 2023
DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...
May 19, 2023
Showing 21 - 30 of 120 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster